Home  /  Resource Library  /  Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line: A population based study of 736 patients

Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line: A population based study of 736 patients

Study examined outcomes of patients with relapsed DLBCL treated with various therapies.